✕
Get authentic, real-time news that helps you fight COVID-19 better.
Install for doctors. It's free.
Install for doctors. It's free.
"COVID brain" or "brain fog" is characterized by confusion, headaches, and loss of short-term memory. In severe cases, it can lead to psychosis and even seizures. Researchers report an underlying cause of COVID brain: the presence of inflammatory molecules in the liquid surrounding the brain and spinal cord - CSF.
SARS-CoV-2 infection induces a wide spectrum of neurologic dysfunction that emerges weeks after the acute respiratory infection. To better understand this pathology, researchers prospectively analyzed a cohort of cancer patients with neurologic manifestations of COVID-19, including a targeted proteomics analysis of the cerebrospinal fluid.
--Cancer patients with neurologic sequelae of COVID-19 harbor leptomeningeal inflammatory cytokines in the absence of viral neuroinvasion.
--The majority of these inflammatory mediators are driven by type II interferon and are known to induce neuronal injury in other disease states.
--In these patients, levels of matrix metalloproteinase-10 within the spinal fluid correlate with the degree of neurologic dysfunction.
--Furthermore, this neuroinflammatory process persists weeks after convalescence from an acute respiratory infection.
--These prolonged neurologic sequelae following systemic cytokine release syndrome lead to long-term neurocognitive dysfunction.
In particular, anti-inflammatory treatment(s) in the management of neurologic complications of COVID-19 infection can be beneficial.
Cancer Cell
Source: https://doi.org/10.1016/j.ccell.2021.01.007
SARS-CoV-2 infection induces a wide spectrum of neurologic dysfunction that emerges weeks after the acute respiratory infection. To better understand this pathology, researchers prospectively analyzed a cohort of cancer patients with neurologic manifestations of COVID-19, including a targeted proteomics analysis of the cerebrospinal fluid.
--Cancer patients with neurologic sequelae of COVID-19 harbor leptomeningeal inflammatory cytokines in the absence of viral neuroinvasion.
--The majority of these inflammatory mediators are driven by type II interferon and are known to induce neuronal injury in other disease states.
--In these patients, levels of matrix metalloproteinase-10 within the spinal fluid correlate with the degree of neurologic dysfunction.
--Furthermore, this neuroinflammatory process persists weeks after convalescence from an acute respiratory infection.
--These prolonged neurologic sequelae following systemic cytokine release syndrome lead to long-term neurocognitive dysfunction.
In particular, anti-inflammatory treatment(s) in the management of neurologic complications of COVID-19 infection can be beneficial.
Cancer Cell
Source: https://doi.org/10.1016/j.ccell.2021.01.007
1 / 1
Like
Comment
Share
